Abstract
Plasma and aqueous levels of cyclosporin A (CsA) were determined following topical administration of CsA 1% to healthy rabbit eyes and compared with levels obtained when administered to rabbit eyes which had received corneal grafts 7-10 days previously. In addition plasma levels were determined following intramuscular administration of 50 mg CsA and the results compared with those obtained following topical administration. Topical administration to healthy rabbit eyes five times a day for three days resulted in plasma levels of CsA which were similar to those obtained over three days following an intramuscular administration of 50 mg CsA. The plasma levels in both were significantly higher than those obtained following topical administration to rabbit eyes which had received corneal grafts 7-10 days previously. Aqueous levels of CsA were lower than plasma levels, and there was no significant difference between levels obtained when CsA was administered topically to healthy eyes, to eyes which had received corneal grafts, or to the fellow eye.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Donatsch P., Abisch E., Homberger M., Traber R., Trapp M., Voges R. A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay. 1981;2(1):19–32. doi: 10.1080/01971528108062989. [DOI] [PubMed] [Google Scholar]
- Foets B., Vanderveeren P., Missotten L. Inhibition of the allograft reaction in corneal transplantation by cyclosporin A: an experimental study with rabbits. Bull Soc Belge Ophtalmol. 1983;206:21–26. [PubMed] [Google Scholar]
- Hunter P. A., Garner A., Wilhelmus K. R., Rice N. S., Jones B. R. Corneal graft rejection: a new rabbit model and cyclosporin-A. Br J Ophthalmol. 1982 May;66(5):292–302. doi: 10.1136/bjo.66.5.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kana J. S., Hoffmann F., Buchen R., Krolik A., Wiederholt M. Rabbit corneal allograft survival following topical administration of cyclosporin A. Invest Ophthalmol Vis Sci. 1982 May;22(5):686–690. [PubMed] [Google Scholar]
- Keown P. A., Stiller C. R., Ulan R. A., Sinclair N. R., Wall W. J., Carruthers G., Howson W. Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet. 1981 Mar 28;1(8222):686–689. doi: 10.1016/s0140-6736(81)91971-1. [DOI] [PubMed] [Google Scholar]
- Morris P. J. Cyclosporin A. Transplantation. 1981 Nov;32(5):349–354. [PubMed] [Google Scholar]
- Morris P. J. Some experimental and clinical studies of Cyclosporin A in renal transplantation. Transplant Proc. 1982 Sep;14(3):525–528. [PubMed] [Google Scholar]
- Salisbury J. D., Gebhardt B. M. Suppression of corneal allograft rejection by cyclosporin A. Arch Ophthalmol. 1981 Sep;99(9):1640–1643. doi: 10.1001/archopht.1981.03930020514024. [DOI] [PubMed] [Google Scholar]
- Shepherd W. F., Coster D. J., Fook T. C., Rice N. S., Jones B. R. Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br J Ophthalmol. 1980 Mar;64(3):148–153. doi: 10.1136/bjo.64.3.148. [DOI] [PMC free article] [PubMed] [Google Scholar]